Last reviewed · How we verify
Tafluprost, timolol maleate
Tafluprost, timolol maleate is a Small molecule drug developed by Santen Pharmaceutical (Taiwan) Co., LTD. It is currently in Phase 2 development. Also known as: latanoprost, tafluprost, bimatoprost, travoprost.
At a glance
| Generic name | Tafluprost, timolol maleate |
|---|---|
| Also known as | latanoprost, tafluprost, bimatoprost, travoprost |
| Sponsor | Santen Pharmaceutical (Taiwan) Co., LTD |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues
- A Study of DE-111A on the Treatment of Open Angle Glaucoma or Ocular Hypertension (PHASE3)
- Preservative-free Fixed-dose Combination of Tafluprost 0.0015% / Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension: Clinical Effectiveness, Tolerability and Safety in a Real World Setting
- From Preserved, to Preservative-free Cyclosporine 0.1% Enhanced Triple Glaucoma Therapy (NA)
- 24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration. (PHASE4)
- Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing (PHASE4)
- 24-hour Efficacy and Ocular Surface With Talfuprost and Triple Combined Therapy (PHASE4)
- Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tafluprost, timolol maleate CI brief — competitive landscape report
- Tafluprost, timolol maleate updates RSS · CI watch RSS
- Santen Pharmaceutical (Taiwan) Co., LTD portfolio CI
Frequently asked questions about Tafluprost, timolol maleate
What is Tafluprost, timolol maleate?
Tafluprost, timolol maleate is a Small molecule drug developed by Santen Pharmaceutical (Taiwan) Co., LTD.
Who makes Tafluprost, timolol maleate?
Tafluprost, timolol maleate is developed by Santen Pharmaceutical (Taiwan) Co., LTD (see full Santen Pharmaceutical (Taiwan) Co., LTD pipeline at /company/santen-pharmaceutical-taiwan-co-ltd).
Is Tafluprost, timolol maleate also known as anything else?
Tafluprost, timolol maleate is also known as latanoprost, tafluprost, bimatoprost, travoprost.
What development phase is Tafluprost, timolol maleate in?
Tafluprost, timolol maleate is in Phase 2.
Related
- Manufacturer: Santen Pharmaceutical (Taiwan) Co., LTD — full pipeline
- Also known as: latanoprost, tafluprost, bimatoprost, travoprost
- Compare: Tafluprost, timolol maleate vs similar drugs
- Pricing: Tafluprost, timolol maleate cost, discount & access